Nest Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 0.53 Cr
as on 02-07-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.48 Cr
as on 02-07-2024
- Revenue 42.98%
(FY 2020)
- Profit 71.56%
(FY 2020)
- Ebitda -325.20%
(FY 2020)
- Net Worth -12.51%
(FY 2020)
- Total Assets -14.08%
(FY 2020)
About Nest Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.53 Cr.
The company currently has active open charges totaling ₹4.80 M.
Raghu Reddy, Madhukar Gujjula, and Vijender Kalluri serve as directors at the Company.
- CIN/LLPIN
U24233TG2009PTC063111
- Company No.
063111
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nest Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhukar Gujjula  | Managing Director | 19-Mar-2009 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raghu Reddy | Additional Director | 18-Apr-2024 | Current |
| Vijender Kalluri | Additional Director | 27-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Nest Pharma.
Nest Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 42.98% increase. The company also saw a substantial improvement in profitability, with a 71.56% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nest Pharma?
In 2020, Nest Pharma had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 24 Apr 2014 | ₹4.80 M | Open |
How Many Employees Work at Nest Pharma?
Nest Pharma has a workforce of 14 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nest Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nest Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
